215 related articles for article (PubMed ID: 26859792)
21. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
[TBL] [Abstract][Full Text] [Related]
22. Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms.
El Charif O; Mapes B; Trendowski MR; Wheeler HE; Wing C; Dinh PC; Frisina RD; Feldman DR; Hamilton RJ; Vaughn DJ; Fung C; Kollmannsberger C; Mushiroda T; Kubo M; Gamazon ER; Cox NJ; Huddart R; Ardeshir-Rouhani-Fard S; Monahan P; Fossa SD; Einhorn LH; Travis LB; Dolan ME
Clin Cancer Res; 2019 Jul; 25(13):4104-4116. PubMed ID: 30952644
[TBL] [Abstract][Full Text] [Related]
23. [Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs ].
Wrześniok D; Buszman E; Matusiński B
Wiad Lek; 2003; 56(7-8):369-74. PubMed ID: 14969167
[TBL] [Abstract][Full Text] [Related]
24. Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies.
Lanvers-Kaminsky C; Zehnhoff-Dinnesen AA; Parfitt R; Ciarimboli G
Clin Pharmacol Ther; 2017 Apr; 101(4):491-500. PubMed ID: 28002638
[TBL] [Abstract][Full Text] [Related]
25. Ototoxicity prognostic models in adult and pediatric cancer patients: a rapid review.
DeBacker JR; McMillan GP; Martchenke N; Lacey CM; Stuehm HR; Hungerford ME; Konrad-Martin D
J Cancer Surviv; 2023 Feb; 17(1):82-100. PubMed ID: 36729346
[TBL] [Abstract][Full Text] [Related]
26. Understanding drug ototoxicity: molecular insights for prevention and clinical management.
Yorgason JG; Fayad JN; Kalinec F
Expert Opin Drug Saf; 2006 May; 5(3):383-99. PubMed ID: 16610968
[TBL] [Abstract][Full Text] [Related]
27. Ototoxicity monitoring through the eyes of the treating physician: Perspectives from pulmonology and medical oncology.
Garinis AC; Cornell A; Allada G; Fennelly KP; Maggiore RJ; Konrad-Martin D
Int J Audiol; 2018 Sep; 57(sup4):S19-S24. PubMed ID: 28978238
[TBL] [Abstract][Full Text] [Related]
28. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
[TBL] [Abstract][Full Text] [Related]
29. A Study on Prevalence and Determinants of Ototoxicity During Treatment of Childhood Cancer (SOUND): Protocol for a Prospective Study.
Diepstraten FA; Meijer AJ; van Grotel M; Plasschaert S; Hoetink AE; Fiocco M; Janssens GO; Stokroos RJ; van den Heuvel-Eibrink MM
JMIR Res Protoc; 2022 Apr; 11(4):e34297. PubMed ID: 35389352
[TBL] [Abstract][Full Text] [Related]
30. Ototoxicity in children with malignant brain tumors treated with the "8 in 1" chemotherapy protocol.
Ilveskoski I; Saarinen UM; Wiklund T; Perkkiö M; Salmi TT; Lanning M; Mäkipernaa A; Pihko H
Med Pediatr Oncol; 1996 Jul; 27(1):26-31. PubMed ID: 8614387
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of cisplatin ototoxicity and progress in otoprotection.
Rybak LP
Curr Opin Otolaryngol Head Neck Surg; 2007 Oct; 15(5):364-9. PubMed ID: 17823555
[TBL] [Abstract][Full Text] [Related]
32. Drug-induced hearing loss.
Prescrire Int; 2014 Dec; 23(155):290-4. PubMed ID: 25629145
[TBL] [Abstract][Full Text] [Related]
33. Pattern of ototoxicity in a Nigerian teaching hospital.
Salisu AD; Hasheem MG
Niger J Med; 2010; 19(3):320-3. PubMed ID: 20845639
[TBL] [Abstract][Full Text] [Related]
34. Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.
Peleva E; Emami N; Alzahrani M; Bezdjian A; Gurberg J; Carret AS; Daniel SJ
Pediatr Blood Cancer; 2014 Nov; 61(11):2012-7. PubMed ID: 24976616
[TBL] [Abstract][Full Text] [Related]
35. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
Bertolini P; Lassalle M; Mercier G; Raquin MA; Izzi G; Corradini N; Hartmann O
J Pediatr Hematol Oncol; 2004 Oct; 26(10):649-55. PubMed ID: 15454836
[TBL] [Abstract][Full Text] [Related]
36. Cancer survivors treated with platinum-based chemotherapy affected by ototoxicity and the impact on quality of life: a narrative synthesis systematic review.
Pearson SE; Taylor J; Patel P; Baguley DM
Int J Audiol; 2019 Nov; 58(11):685-695. PubMed ID: 31545660
[No Abstract] [Full Text] [Related]
37. High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis.
Al-Malky G; Dawson SJ; Sirimanna T; Bagkeris E; Suri R
J Cyst Fibros; 2015 Mar; 14(2):248-54. PubMed ID: 25127922
[TBL] [Abstract][Full Text] [Related]
38. Ototoxicity in Nigeria: why it persists.
Kokong DD; Bakari A; Ahmad BM
Ear Nose Throat J; 2014 Jul; 93(7):256-64. PubMed ID: 25025411
[TBL] [Abstract][Full Text] [Related]
39. A new grading system for ototoxicity in adults.
Theunissen EA; Dreschler WA; Latenstein MN; Rasch CR; van der Baan S; de Boer JP; Balm AJ; Zuur CL
Ann Otol Rhinol Laryngol; 2014 Oct; 123(10):711-8. PubMed ID: 24820112
[TBL] [Abstract][Full Text] [Related]
40. Correlation of otologic complaints in soldiers with speech disorders after traumatic brain injury.
Dion GR; Miller CL; O'Connor PD; Howard NS
J Voice; 2014 Jan; 28(1):88-91. PubMed ID: 24275459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
